Understanding how cochlear implants help people hear over time
Assessing Longitudinal Changes In Peripheral Versus Central Processing of Newly Implanted Cochlear Implant Recipients
This study is looking at how new cochlear implants help people hear better during the first six months, focusing on both how the implant works and how the brain processes sound, to understand why some people hear speech differently than others.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11161046 on NIH RePORTER |
What this research studies
This research investigates how newly implanted cochlear implants affect hearing over the first six months of use. It focuses on both the peripheral aspects, such as how well the implant stimulates the auditory nerve, and the central processing of sound in the brain. By measuring various factors at different levels of the auditory system, the study aims to uncover the reasons behind the variability in speech perception among cochlear implant recipients. Patients will undergo a series of tests to assess their acclimatization process and overall auditory performance.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have recently received cochlear implants.
Not a fit: Patients who are not candidates for cochlear implants or those who have had their implants for more than six months may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cochlear implant designs and rehabilitation strategies, enhancing speech perception for recipients.
How similar studies have performed: Previous research has shown that understanding the acclimatization process can lead to better outcomes for cochlear implant users, indicating that this approach has potential for success.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Hem, Charles Beal — Harvard Medical School
- Study coordinator: Hem, Charles Beal
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.